Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Carcinoma, Hepatocellular 20Sarcoma 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Endometrial Neoplasms 14Leukemia 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

pembrolizumab 1Vincristine 1Vinblastine 1Procarbazine 1Prednisone 1Methotrexate 1Mercaptopurine 1Magnetic Resonance Imaging 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Data Collection 1Cytarabine 1Cyclophosphamide 1Caspofungin 1Blood Specimen Collection 1BAY 1895344 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ataxia Telangiectasia × Blood Specimen Collection × Clear all
NCT03357978 2017-11-30

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Johann Wolfgang Goethe University Hospital

Phase NA Unknown
30 enrolled

Ataxia Telangiectasia, Immunologic Deficiency Syndromes, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡